Table 3.
Parameter | Baseline | Follow-up | p value |
---|---|---|---|
Serum CRP (ng/mL) | 3.5 ± 1.5 | 2.8 ± 1.6 | 0.02∗ |
Serum IL-1 (pg/mL) | 0.39 ± 0.38 | 0.35 ± 0.41 | 0.7 |
Serum IL-2 (pg/mL) | 26.0 ± 128 | 17.2 ± 82 | 0.3 |
Serum IL-4 (pg/mL) | 0.24 ± 0.15 | 1.37 ± 6.1 | 0.3 |
Serum IL-5 (pg/mL) | 36.9 ± 137 | 15.5 ± 45.5 | 0.2 |
Serum IL-6 (pg/mL) | 29.9 ± 80.1 | 20.9 ± 47.9 | 0.5 |
Serum IL-10 (pg/mL) | 3.9 ± 2.9 | 3.3 ± 2.9 | 0.3 |
Serum IL-12 (pg/mL) | 1.0 ± 3.7 | 0.5 ± 1.4 | 0.3 |
Serum IL-13 (pg/mL) | 0.4 ± 0.4 | 0.3 ± 0.4 | 0.3 |
Serum IFN-γ (pg/mL) | 0.93 ± 0.93 | 2.1 ± 7.6 | 0.4 |
Serum TNF-α (pg/mL) | 0.58 ± 0.6 | 0.37 ± 0.5 | 0.2 |
Urinary TGF-β (pg/mL) | 14.8 ± 16.3 | 17.7 ± 19.9 | 0.4 |
CRP: C-reactive protein; IL: interleukin; IFN: interferon; TNF: tumor necrosis factor; TGF: transforming growth factor.
∗Statistically significant.